newsfilter
← Latest News
Business Wire·

AgeX Therapeutics Receives Stock Exchange Deficiency Letter

AgeX Therapeutics , Inc. (NYSE:AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 17, 2021 it received a letter (the "Deficiency Letter") from the staff of the NYSE American (the "Exc